All News #Library
Rare Diseases
AMO Pharma Reveals REACHCDM-X Study`s Safety Data for AMO-02
15 Sep 2025 //
PR NEWSWIRE
AMO Pharma, PHRI, Venca Research License Deal for ARVC Study
08 Sep 2025 //
PR NEWSWIRE

Market Place
Sourcing Support